JWM
RCEL icon

JPL Wealth Management’s Avita Medical RCEL Stock Holding History

JPL Wealth Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Buy
6
+1
+20% +$4 ﹤0.01% 1786
2026
Q1 		$19 Buy
+5
New +$21 ﹤0.01% 1537
2025
Q4 		– Sell
-5
Closed -$26 – 887
2025
Q3 		$26 Buy
+5
New +$26 ﹤0.01% 1189

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JPL Wealth Management's RCEL Position: Q2 2026 in Review

JPL Wealth Management increased its Avita Medical (RCEL) stake by 20% in Q2 2026, buying an estimated $4 and bringing the position to 6 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #1786.

JPL Wealth Management first reported a position in RCEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $26 in Q3 2025. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • JPL Wealth Management held 6 shares of Avita Medical worth $25 as of Q2 2026.
  • JPL Wealth Management bought 1 Avita Medical share in Q2 2026, an estimated $4.
  • Avita Medical made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1786 holding.
  • JPL Wealth Management first reported a position in Avita Medical in Q3 2025 and has held it in 3 quarters since.
  • JPL Wealth Management's Avita Medical position peaked at $26 in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.